SAN ANTONIO, June 2, 2020 — CeloNova BioSciences, Inc. announced that it has successfully completed enrollment of the COBRA REDUCE ...
News
- CeloNova Announces Enrollment Completion of World's First Randomized Control, 14-Day DAPT ...
- National coronavirus updates: First human trial of potential antibody treatment begins
The treatment was created in collaboration with AbCellera, a biotechnology company based in Canada. When someone recovers from a disease like ...
- Gilead says drug helped moderately ill coronavirus patients
WASHINGTON (AP) — A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to ...
- Other news to note for June 1, 2020
Celonova Biosciences Inc., of San Antonio, Texas, completed enrollment of the COBRA REDUCE randomized control trial evaluating the safety and ...
- Coty, Beyond Meat rise; Pfizer, Gilead Sciences fall
The latest results from the biotechnology company's study of a potential COVID-19 treatment disappointed investors. Beyond Meat Inc., up $10.40 to ...